Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation.

Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation. Oncotarget. 2019 May 14;10(35):3209-3226 Authors: Ullah H, Hou W, Dakshanamurthy S, Tang Q Abstract Due to the small number of molecular targets in viruses and the rapid evolution of viral genes, it is very challenging to develop specific antiviral drugs. Viruses require host factors to translate their transcripts, and targeting the host factor(s) offers a unique opportunity to develop broad antiviral drugs. It is well documented that some viruses utilize a host protein, Receptor for Activated C Kinase 1 (RACK1), to translate their mRNAs using a viral mRNA secondary structure known as the Internal Ribosomal Entry Site (IRES). RACK1 is essential for the translation of many viruses including hepatitis C (HCV), polio, Drosophila C (DCV), Dengue, Cricket Paralysis (CrpV), and vaccinia viruses. In addition, HIV-1 and Herpes Simplex virus (HSV-1) are known to use IRES as well. Therefore, host RACK1 protein is an attractive target for developing broad antiviral drugs. Depletion of the host's RACK1 will potentially inhibit virus replication. This background study has led us to the development of novel antiviral therapeutics, such as RACK1 inhibitors. By utilizing the crystal structure of the RACK1A protein from the model plant Arabidopsis and using a structure based drug design method, dozens of small compounds were identified that c...
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research

Related Links:

Elecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virus (anti-HAV IgM) in human serum and plasma Catalog number: 07026773190
Source: Medical Device Recalls - Category: Medical Devices Source Type: alerts
Blood tests can usually show whether a person has hepatitis C. However, these tests can give false-positive readings. Here, learn why this can happen.
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Liver Disease / Hepatitis Source Type: news
ConclusionHCV infection was common in certain districts of Punjab and common in adults of 40–60 years. This finding needs to be confirmed in larger population-based study. The IV drug abuse is the risk factor of concern among young adults.
Source: Medical Journal Armed Forces India - Category: General Medicine Source Type: research
This study modeled the prevention impact achieved from initiating a treat-all policy for HCV compared with treating different subgroups at country, regional and global levels.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Conditions:   Hepatitis B;   Compensated Cirrhosis Interventions:   Drug: Entecavir;   Drug: Tenofovir Disoproxil Fumarate;   Drug: Tenofovir alafenamide Sponsor:   Third Affiliated Hospital, Sun Yat-Sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Chronic obstructive pulmonary disease (COPD) has few treatment options, with patients frequently experiencing shortness of breath. To address this most unwelcome symptom of COPD, Dr. Jake Brenner, a critical care physician specializing in pulmonology...
Source: Medgadget - Category: Medical Devices Authors: Tags: Cardiology Critical Care Source Type: blogs
THURSDAY, Dec. 12, 2019 -- Last October, 15-year-old Alec Woodruff developed a strange-sounding cough. Less than a week later, he was fighting for his life in the hospital, partially paralyzed and with a tube in his throat attached to a ventilator...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
M. Kaddoura et al.
Source: Emerging Infectious Diseases Journal - Category: Infectious Diseases Source Type: research
(Harvard Medical School) Scientists have used the gene-editing tool CRISPR-Cas9 to disrupt both latent reservoirs of the herpes simplex virus and actively replicating virus in human fibroblast cells. Experiments pinpoint weak spot that can make the virus susceptible to gene editing.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
Publication date: 10 December 2019Source: Cell Reports, Volume 29, Issue 11Author(s): Guangyun Tan, Zhaohong Yi, Hongxiao Song, Fengchao Xu, Feng Li, Roghiyh Aliyari, Hong Zhang, Peishuang Du, Yanhua Ding, Junqi Niu, Xiaosong Wang, Lishan Su, F. Xiao-Feng Qin, Genhong ChengSummaryTo understand the molecular mechanisms that mediate the anti-hepatitis B virus (HBV) effect of interferon (IFN) therapy, we conduct high-throughput bimolecular fluorescence complementation screening to identify potential physical interactions between the HBx protein and 145 IFN-stimulated genes (ISGs). Seven HBx-interacting ISGs have con...
Source: Cell Reports - Category: Cytology Source Type: research
More News: Acyclovir | Cancer & Oncology | Cold Sores | Dengue Fever | Genetics | Hepatitis | Hepatitis C | Herpes | Middle East Health | Polio | Study | Zovirax